KaloBios offered financing in plan to buy drug for Chagas disease
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Brooklyn
KALOBIOS Pharmaceuticals Inc, the drug company that plunged into bankruptcy after the arrest of its former chief executive officer Martin Shkreli, is getting some help for its plan to buy a treatment for Chagas disease.
Hedge fund Black Horse Capital LP offered to buy at least 40 per cent of the company for US$10 million on the condition that Shkreli holds no more than 20 per cent of KaloBios' voting shares, according to a filing on Thursday in Delaware bankruptcy court. Shkreli had owned about 50 per cent of the stock before the bankruptcy. At least a substantial portion of his stake was used to secure his US$5 million bail after he was charged with securities fraud in December.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
